Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zonisamide vs carbamazepine monotherapy in newly diagnosed partial epilepsy
2006-000156-40Phase 3Terminated
- Sponsor
- Eisai Co., Ltd.
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in epilepsy comparing Zonisamide monotherapy with Carbamazepine monotherapy (2 arms). Primary endpoint: 26-week seizure-free rate. Started Mar 2007; status: terminated.
02
Drugs
zonisamidecarbamazepine
03
Conditions
epilepsy
Beyond the preview
Go deeper on 2006-000156-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000156-40.